Cobimetinib(Cotellic)

Cobimetinib first received marketing authorization in the European Union in 2015. It is a highly selective, reversible allosteric inhibitor of mitogen-activated protein kinase (MEK) 1/2.

20mg*63tablets

WhatsApp

To ensure medication safety, consult customer service for free before purchasing. Returns/exchanges are not accepted except for quality issues.

Authentic

Guarantee

Fast Delivery

Privacy

Cobimetinib Purchase Guide

What are the purchasing channels for cobimetinib

Cobimetinib (Cotellic) is a targeted therapy for the treatment of melanoma with BRAF V600 mutation. Reliable procurement channels and standardized adm···【Read More】
Update: 28 Feb,2026Source: Haiou HealthViews: 71
How many boxes of cobimetinib are needed per treatment course and how much does it cost

Cobimetinib is a targeted therapy for melanoma with BRAF V600E/K mutation. The dosage per treatment cycle and treatment cost are key concerns for pati···【Read More】
Update: 28 Feb,2026Source: Haiou HealthViews: 71